Advanced search×

Atrial flutter catheter ablation in adult patients with repaired tetralogy of Fallot: mechanisms and outcomes of percutaneous catheter ablation in a consecutive series.

J Interv Card Electrophysiol 28(2):125-35 (2010) PMID 20390332

Prior investigators note successful ablation of both typical cavotricuspid isthmus-dependent and scar-related macroreentrant right atrial flutters (AFL) in adult patients with repaired tetralogy of Fallot (TOF). However, an analysis of the mechanisms (including a description of a uniform approach to diagnose such mechanisms), and clinical outcomes of catheter ablation in a consecutive series of adult patients with AFL late after surgical TOF repair has not been previously reported.

DOI: 10.1007/s10840-010-9477-5
Version: za2963e q8za5 q8zba q8zc7 q8zdf q8ze0 q8zf4 q8zg3

Similar articles you may find interesting…

  1. Current strategy for treatment of patients with Wolff-Parkinson-White syndrome and asymptomatic preexcitation in Europe: European Heart Rhyt...

    Europace 15(5):750-3 (2013) PMID 23625944

    The aims of this survey was to provide insight into treatment activity, the strategy of treatment, and risk stratification of patients with asymptomatic and symptomatic ventricular pre-excitation across Europe. Fifty-eight centres, members of the European Heart Rhythm Association EP...
  2. Conduction recovery in patients with recurrent atrial fibrillation after pulmonary vein isolation using multi-electrode duty cycled radiofre...

    J Interv Card Electrophysiol (2013) PMID 23636869

    The pulmonary vein ablation catheter (PVAC) is designed for pulmonary vein isolation (PVI). Electrical reconnection of pulmonary veins is believed to result in AF recurrence. The purpose of this study was to establish the location and extent of PV reconnection after PVI with the PVAC catheter. METHO...
  3. A novel approach to treat residual peridevice leakage after left-atrial appendage closure.

    Catheter Cardiovasc Interv (2013) PMID 23629764

    Left atrial appendage (LAA) device closure has emerged as an alternative treatment to conventional anticoagaluation therapy for the prevention of thromboembolic events in patients with atrial fibrillation. In 8-10% of patients with interventional LAA obliteration, relevant residual f...